Digest Network Come funziona
Network
/
Società
Bl
Non verificato

Blue Earth Diagnostics

Di cosa scriviamo

BiotecnologiaEventiIndustriaOncologiaSalute

4 comunicati stampa

Guarda tutti i comunicati
04/11/2024
Industria
Oncologia
Salute
Medicina nucleare
Farmaceutica
Biotecnologia
Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals
Fonte
Blue Earth Diagnostics
Emittente
Business Wire
1.00
0
01/10/2024
Multimedialità
Eventi
Fiere
Industria
Oncologia
Salute
Medicina nucleare
Medicina - Varie
Farmaceutica
Biotecnologia
Results of POSLUMA® (Flotufolastat F 18) Performance in Recurrent Prostate Cancer After Radical Prostatectomy at Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO
Fonte
Blue Earth Diagnostics
Emittente
Business Wire
1.00
0
24/09/2024
Eventi
Industria
Biotecnologia
Salute
Medicina nucleare
Farmaceutica
Oncologia
Blue Earth Diagnostics Highlights Presentations on POSLUMA® (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting
Fonte
Blue Earth Diagnostics
Emittente
Business Wire
1.00
0
30/07/2024
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA® (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer
Fonte
Blue Earth Diagnostics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0